Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
Introduction: To assess whether switching from Ranibizumab to Aflibercept conferred benefit in visual acuity (VA) and central macular thickness (CMT) in patients with wet age-related macular degeneration (AMD). Methods: Mean change in VA and CMT was assessed in wet AMD patients 6 months prior and 6...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Collection: | Delhi Journal of Ophthalmology |
| Sujets: | |
| Accès en ligne: | https://journals.lww.com/10.7869/djo.625 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|